## FCX: Freeport-McMoRan Inc. - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_10 2.4% below STRENGTH zone (3.0-6.0%); PEG 4.54 fails VALUE criteria (<1.0); RSI 72 overbought. Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.9% MRS), overbought RSI (72).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($48.48)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 2, Bearish: 6)

**1. FCX Investors Have Opportunity to Lead Freeport-McMoRan Inc. Securities Fraud Lawsuit with the Schall Law Firm**
- Source: GlobeNewswire | 20251229T151019 | Bearish | Relevance: 100%
- The Schall Law Firm reminds investors of a class action lawsuit against Freeport-McMoRan Inc. (NYSE: FCX) for alleged securities fraud between February 15, 2022, and September 24, 2025. The lawsuit claims Freeport-McMoRan made false statements regarding safety practices at its Grasberg Block Cave mine in Indonesia, leading to investor losses. Shareholders who suffered losses are encouraged to contact the firm by January 12, 2026.

**2. Annex Advisory Services LLC Has $37.70 Million Holdings in Freeport-McMoRan Inc. $FCX**
- Source: MarketBeat | 20251229T081722 | Neutral | Relevance: 100%
- Annex Advisory Services LLC increased its stake in Freeport-McMoRan Inc. (NYSE:FCX) by 4.8% in Q3, now owning 961,212 shares valued at $37.70 million. The company benefits from a strong copper rally and positive analyst ratings, although it faces risks from rising short interest and multiple class-action lawsuits. Various institutional investors have also adjusted their positions in FCX, which recently reported strong quarterly earnings and declared a $0.075 quarterly dividend.

**3. Freeport-McMoRan ends week higher as copper prices hit fresh records**
- Source: ts2.tech | 20251229T020812 | Bullish | Relevance: 100%
- Freeport-McMoRan (NYSE: FCX) shares ended the week higher, gaining 2.2% to $53.04, as global copper prices surged to new records. Copper reached nearly 100,000 yuan a tonne in Shanghai and over $5.90 a pound in New York, driven by increased demand for electrification projects and expectations of Federal Reserve rate cuts. Traders are monitoring the reopening of the London market and continued tariff-driven price gaps.

**4. FCX INVESTOR DEADLINE: Freeport McMoRan Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit**
- Source: TMX Newsfile | 20251228T190812 | Bearish | Relevance: 100%
- Robbins Geller Rudman & Dowd LLP announces a class action lawsuit against Freeport-McMoRan Inc. (NYSE: FCX) for purchasers of its publicly traded securities between February 15, 2022, and September 24, 2025. Investors who suffered substantial losses have until January 12, 2026, to seek appointment as lead plaintiff. The lawsuit alleges that Freeport-McMoRan made false statements regarding safety at its Grasberg Block Cave mine in Indonesia, leading to worker fatalities and significant stock price drops.

**5. Bronstein, Gewirtz & Grossman LLC Urges Freeport-McMoRan Inc. Investors to Act: Class Action Filed Alleging Investor Harm**
- Source: ABC27 | 20251228T170837 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Freeport-McMoRan Inc. (NYSE: FCX) alleging that the company made false and misleading statements regarding safety at its Grasberg Block Cave mine in Indonesia. Investors who purchased Freeport securities between February 15, 2022, and September 24, 2025, are encouraged to join the lawsuit, which claims that the lack of proper safety precautions constituted an undisclosed heightened risk leading to investor damages. The firm offers contingency-fee representation and provides details on how investors can participate as lead plaintiff by January 12, 2026.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-23 | Wells Fargo | $55 | $47 | +17% |
| 2025-12-12 | UBS | $60 | $55 | +9% |
| 2025-12-05 | JP Morgan | $58 | $50 | +16% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-23 | Wells Fargo | main | Overweight |
| 2025-12-12 | UBS | main | Buy |
| 2025-12-05 | JP Morgan | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.05M) |
| Sells | 3 ($1.82M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.0% (+1.4%)
- Blackrock Inc.: 7.4% (+0.6%)
- Fisher Asset Managem: 4.4% (+1.4%)
- State Street Corpora: 4.3% (+1.1%)
- Capital Research Glo: 2.9% (-31.2%)

### Key Risks

1. Valuation risk: PEG 4.5x with declining EPS estimates leaves no margin for error.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +14%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 4.54 signals overvaluation risk, limited margin of safety. Forward P/E 22.4x attractive for 49% earnings growth. Balance sheet: strong liquidity (2.5x). Analyst sentiment positive (3 raises, avg +14%). Insider selling cluster ($1.8M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $73.9B |
| Beta | 1.48 |
| 52W Range | $27.66 - $53.77 |
| Short Interest | 2.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.54 |
| Forward P/E | 22.4 |
| Current P/E | 33.5 |
| YoY Growth | 49.3% |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from 5.3% to 2.4% (-2.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 0.6pp (needs >3.0% for momentum thesis). MRS_5 (-0.3%) diverging from MRS_10 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 72, risk of mean reversion. OFD pattern: -SUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.39% (CS: 96) | Neutral |
| RSI_14 | 71.6 | Overbought |
| MACD Histogram | 0.42 | Bullish |
| vs SMA20 | 1.083x | Above |
| vs SMA50 | 1.182x | Above |
| vs SMA200 | 1.243x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $51.48
- **Stop Loss:** $48.48 (5.8% risk)
- **Target:** $54.48 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 460
- **Position Value:** $23,680.80
- **Portfolio %:** 23.68%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with selective risk appetite and defensive rotation. VIX at 14.2 (2nd percentile) signals low volatility, while positive yield curve (+58bps) and stable economic indicators support continued expansion. Market breadth at 58.7% shows decent participation, but rotation into defensive names and Fed liquidity concerns warrant measured positioning.*

### Earnings

**Next:** 2026-01-22 (Est: $0.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.41 | $0.50 | +22.8% |
| 2025Q2 | $0.44 | $0.54 | +21.8% |
| 2025Q1 | $0.23 | $0.24 | +4.6% |
| 2024Q4 | $0.22 | $0.31 | +43.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*